Ligand Pharmaceuticals Statistics
Total Valuation
BMV:TTWO has a market cap or net worth of MXN 767.05 billion. The enterprise value is 794.54 billion.
Market Cap | 767.05B |
Enterprise Value | 794.54B |
Important Dates
The last earnings date was Wednesday, August 6, 2025.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 184.47M |
Shares Outstanding | n/a |
Shares Change (YoY) | +3.75% |
Shares Change (QoQ) | +2.26% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 171.99M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 45.99 |
PS Ratio | 7.01 |
PB Ratio | 11.69 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 61.64, with an EV/FCF ratio of -722.68.
EV / Earnings | -9.96 |
EV / Sales | 7.34 |
EV / EBITDA | 61.64 |
EV / EBIT | n/a |
EV / FCF | -722.68 |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 1.01.
Current Ratio | 1.16 |
Quick Ratio | 0.99 |
Debt / Equity | 1.01 |
Debt / EBITDA | 5.08 |
Debt / FCF | -60.15 |
Interest Coverage | -1.69 |
Financial Efficiency
Return on equity (ROE) is -89.29% and return on invested capital (ROIC) is -2.18%.
Return on Equity (ROE) | -89.29% |
Return on Assets (ROA) | -1.65% |
Return on Invested Capital (ROIC) | -2.18% |
Return on Capital Employed (ROCE) | -4.35% |
Revenue Per Employee | 8.46M |
Profits Per Employee | -6.17M |
Employee Count | 12,928 |
Asset Turnover | 0.51 |
Inventory Turnover | n/a |
Taxes
Income Tax | -1.21B |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.74% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +55.74% |
50-Day Moving Average | 4,402.87 |
200-Day Moving Average | 4,098.82 |
Relative Strength Index (RSI) | 41.51 |
Average Volume (20 Days) | 159 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 3.95 |
Income Statement
In the last 12 months, BMV:TTWO had revenue of MXN 109.36 billion and -79.75 billion in losses. Loss per share was -450.00.
Revenue | 109.36B |
Gross Profit | 65.07B |
Operating Income | -5.63B |
Pretax Income | -80.96B |
Net Income | -79.75B |
EBITDA | 11.33B |
EBIT | -5.63B |
Loss Per Share | -450.00 |
Balance Sheet
The company has 38.38 billion in cash and 66.13 billion in debt, giving a net cash position of -27.76 billion.
Cash & Cash Equivalents | 38.38B |
Total Debt | 66.13B |
Net Cash | -27.76B |
Net Cash Per Share | n/a |
Equity (Book Value) | 65.64B |
Book Value Per Share | 355.98 |
Working Capital | 8.75B |
Cash Flow
In the last 12 months, operating cash flow was 1.91 billion and capital expenditures -3.01 billion, giving a free cash flow of -1.10 billion.
Operating Cash Flow | 1.91B |
Capital Expenditures | -3.01B |
Free Cash Flow | -1.10B |
FCF Per Share | n/a |
Margins
Gross margin is 59.50%, with operating and profit margins of -5.15% and -72.92%.
Gross Margin | 59.50% |
Operating Margin | -5.15% |
Pretax Margin | -74.03% |
Profit Margin | -72.92% |
EBITDA Margin | 10.36% |
EBIT Margin | -5.15% |
FCF Margin | n/a |
Dividends & Yields
BMV:TTWO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.75% |
Shareholder Yield | n/a |
Earnings Yield | -10.40% |
FCF Yield | -0.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BMV:TTWO has an Altman Z-Score of 2.73 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.73 |
Piotroski F-Score | 6 |